BLOXR Launches Revolutionary UltraBLOX X-Ray Attenuating Cream, a Novel Radiation Shield for the Protection of Doctor’s Hands
(September 9, 2013 Salt Lake City, UT), BLOXR Corporation, a developer of radiation protection products made from non-toxic, non-metal materials today announced the launch of their revolutionary X-ray attenuation cream, UltraBLOX.
Diagnostic imaging, in the form of X-rays, fluoroscopy and CT scans, has revolutionized diagnostic radiology. Reports indicate the number of X-rays has exploded to 180 million and the number of CT scans to 60 million annually in the US alone, with ~ 4 million CT scans for children under age 15. The downside is the heightened concern of radiation overexposure to both patients and clinicians alike.
Clinicians who are exposed routinely, for extended hours on a daily basis throughout their long careers, may reach their annual dose limits in a few months of practice. This overexposure to harmful ionizing radiation is far greater than that of other medical staff and is known to pose risks including skin rashes and hair loss.
Clinicians wear protective aprons and thyroid collars to reduce dose exposure, but have limited options for protecting their hands. BLOXR’s novel topically applied radiation attenuation cream, UltraBLOX, provides effective dose reduction without adversely affecting dexterity or tactile feel.
"The UltraBLOX radioprotective cream provides radiation protection to a clinician's hands without changing the tactile feeling or limiting dexterity during surgery" said Dr. Alfonso Mejia, Professor of Orthopaedic Surgery and Vice-Chair, Department of Orthopaedics, University of Illinois Medical Center and Director of their Residency program. "This will allow us to use fluoroscopy while holding or manipulating within the operative field in order to maximize the outcome for the patient without compromising the safety of the surgeon," he added.
“We were pleased that the pre-clinical study on the attenuating cream presented at the 2012 AAOS Annual Meeting was recognized as one of the top stories at that meeting," said Ashok Khandkar, President and Chief Executive Officer of BLOXR. “Launching UltraBLOX is a further demonstration of BLOXR’s commitment to and leadership in the field of providing superior and cost effective radiation protection solutions to healthcare professionals," he said.
About BLOXR
BLOXR is the leading radiation protection company dedicated to making a difference in reducing dose exposure through the development and commercialization of revolutionary XPF technology to uniquely remove the more harmful part of the transmitted energy spectrum. BLOXR’s portfolio of XPF products are based on a deep understanding of the physics of compound filtration and are developed with a committment to eliminate the use of all toxic and hazardous heavy metals. With our focus on innovation, we also pioneered the UltraBLOX radiation attenuating cream to provide unprecendeted dose reduction to users, to provide a comprehensive, highly effective and safe suite of dose reduction solutions across multiple market segments. To learn more about how BLOXR is making a difference, please visit our website at www.bloxr.com.
Media Contact:
BLOXR Corporation
Ginny Rowland, VP Marketing
Phone: 801-590-9888
E-Mail: growland@bloxr.com
or
Chris Green, Marketing Specialist
Phone: 801-590-9895
E-Mail: cgreen@bloxr.com
###
Tags:
